Metaphase II transgenesis.
Since its advent in 1974, at least 11 methods have been developed to introduce potentially heritable exogenous DNA (transgenes; tgs) into mammals. These methods are now briefly reviewed in the context of a nascent method that has been demonstrated by microinjection of membrane-depleted sperm heads and tg DNA into metaphase II (mII) oocytes: mII transgenesis. The efficiency of mII transgenesis is at least as high as that of the well-established and prevailing alternative, pronuclear microinjection. Moreover, mII transgenesis promises to facilitate large tg delivery to assist with the generation of disease models and other paradigms in mammalian genome engineering.